JPMorgan China Growth & Income plc
JCGI.L
London Stock Exchange275.00
GBp
+2.00
- -
JPMorgan China Growth & Income plc
JCGI.L
(London Stock Exchange)
Recent
price
275.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- JPMorgan China Growth & Income plc is a closed-end investment trust that seeks long-term capital growth by investing in equities of companies associated with Greater China, including those in China, Hong Kong, and Taiwan; its portfolio typically comprises 45 to 85 investments quoted on local stock exchanges such as Hong Kong or issuing American Depositary Receipts on other markets like the United States, with allocations across sectors including consumer discretionary, communication services, information technology, industrials, financials, healthcare, real estate, consumer staples, utilities, materials, and energy, while targeting outperformance of the MSCI China Index total return in sterling terms with net dividends reinvested. The trust, incorporated in 1993 and headquartered at 60 Victoria Embankment in London, United Kingdom, is managed by JPMorgan Funds Limited as alternative investment fund manager and employs gearing up to 20% of shareholders' funds alongside a policy of distributing dividends equivalent to at least 4% of the prior year's ending net asset value. Recent developments include an active share buyback program authorizing the repurchase of up to 14.99% of issued share capital, comprising 12,472,049 shares; portfolio adjustments emphasizing high-quality growth names in technology, industrials, internet, and consumer sectors such as Alibaba, Xiaomi, Haidilao, and Kuaishou Technology amid market deratings; increased exposure to China's domestic A-share market surpassing 20% alongside gearing elevated to 10%, reflecting managerial optimism on economic stabilization; and enhancements to the investment team and research processes as outlined in the 2025 half-year report.